04.04.2017 • TopicsDr. Gerd BergmannNordmannNRC

Investment in Digital Technologies

Felix Thalmann, CEO, BÜFA Group
Felix Thalmann, CEO, BÜFA Group

“At BÜFA, the chances of digitalization are weekly discussed in a meeting where members of all our business areas and different business processes take part. We look at every process that is relevant for our value chain — from supplier to customer — and try to find step-by-step digitalization projects that will improve our performance. We are keen to reach a continuous flow of information throughout the supply chain without any media change.

Additionally we ask ourselves if there are possibilities that digitalization could replace the existing business models. This question already led to the formation of BÜFA-i, a start-up within the BÜFA group that develops an online marketplace for chemical trading and that can — among other things — enlarge our geographical reach. Generally, BÜFA seeks to increase efficiency by investing in digital technologies.

The biggest risk I see at the moment concerning digitalization is being too slow. To be able to successfully implement this paradigm shift, it is essential to engage all employees in the process.”

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.